SCHEMBL6842273

SCHEMBL6842273

NC(=O)c1cccc(C2CCCCC2C(=O)Nc2ccc(N3CCCCC3=O)cc2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.59
MAOB P27338 1/20 0.59
SMN1; SMN2 Q16637 5/20 0.48
NPC1 O15118 4/20 0.48
RAB9A P51151 3/20 0.48
ALDH1A1 P00352 2/20 0.48
TP53 P04637 1/20 0.48
GLA P06280 1/20 0.48
PKM P14618 1/20 0.48
F10 P00742 6/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
TSHR P16473 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HRH3 Q9Y5N1 1/20 0.42
HPGD P15428 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6842236 0.98 KDM1A (0.59) KDM1AMAOBSMN1; SMN2NPC1RAB9A
SCHEMBL6835595 0.98 KDM1A (0.59) KDM1AMAOBSMN1; SMN2NPC1RAB9A
SCHEMBL6842235 0.98 KDM1A (0.59) KDM1AMAOBSMN1; SMN2NPC1RAB9A
SCHEMBL6839750 0.84 KDM1A (0.52) KDM1AMAOBSMN1; SMN2NPC1RAB9A
SCHEMBL6835557 0.84 KDM1A (0.52) KDM1AMAOBSMN1; SMN2NPC1RAB9A
Hydrochloric Acid SCHEMBL6835549 0.84 KDM1A (0.51) KDM1AMAOBSMN1; SMN2NPC1RAB9A
Hydrochloric Acid SCHEMBL6835548 0.84 KDM1A (0.51) KDM1AMAOBSMN1; SMN2NPC1RAB9A
SCHEMBL6842234 0.81 KDM1A (0.49) KDM1AMAOBSMN1; SMN2NPC1RAB9A
SCHEMBL6835604 0.79 KDM1A (0.49) KDM1AMAOBSMN1; SMN2NPC1RAB9A
SCHEMBL4745975 0.79 NPC1 (0.48) KDM1AMAOBSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040082563-A1 Phenyl derivatives 3 MERCK PATENT GMBH (DE) 2004-04-29 US claimed
EP-1368341-A1 PHENYL DERIVATIVES 3 MERCK PATENT GmbH (DE) 2003-12-10 EP claimed
WO-2002074765-A1 PHENYL DERIVATIVES 3 MERCK PATENT GMBH (DE) 2002-09-26 WO claimed
US-20040082563-A1 Phenyl derivatives 3 MERCK PATENT GMBH (DE) 2004-04-29 US disclosed
EP-1368341-A1 PHENYL DERIVATIVES 3 MERCK PATENT GmbH (DE) 2003-12-10 EP disclosed
WO-2002074765-A1 PHENYL DERIVATIVES 3 MERCK PATENT GMBH (DE) 2002-09-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082563-A1 Phenyl derivatives 3 F2, F11, F12 KDM1A 452/4885MAOB 435/4885SMN1; SMN2 3408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.